Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

PHENOL RED PH TEST

Active

SPE2DS-26-T-152ZFederal

Response Deadline06/22/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the procurement of three units of Phenol Red pH Test kits, identified by NSN 6550-01-095-6757. It was issued under solicitation number SPE2DS-26-T-152Z by the Defense Logistics Agency, a federal entity within the Department of Defense. The solicitation was posted on June 14, 2026, with a response deadline set for June 22, 2026. This procurement does not specify any set-aside designation or NAICS code and does not provide detailed location information for performance or point of contact. The contract aims to fulfill a requirement for these specific pH test kits for the Department of Defense through the Defense Logistics Agency’s solicitation process.

General Info

Procurement of three Phenol Red pH Test kits via Defense Logistics Agency solicitation, June 2026.

Agency

Department Of Defense → Defense Logistics Agency

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation

PostedJun 14

Solicitation

Response DeadlineJun 22

Submission deadline

Response Deadline

06/22/2026, 05:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUS

Organization / Agency

Department Of Defense → Defense Logistics Agency

Office AddressUS

ContactsNo contact information available

Full Description

Show more

PHENOL RED PH TEST NSN/Part Number: 6550-01-095-6757 Purchase Request: 7017142408QTY: 3

Similar Contracts

CULTURE MEDIUM, ANAEThe contract pertains to the procurement of a culture medium identified as ANAE, with the National Stock Number 6550-01-216-6875. It involves a purchase request for a quantity of one unit. This solicitation, numbered SPE2DS-26-T-155T, was issued by the Defense Logistics Agency under the Department of Defense and posted on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. The contract is classified as a federal solicitation, but there is no specified set-aside or NAICS code associated with it. The place of performance and specific office addresses remain unspecified. The contracting opportunity is accessible via the Defense Logistics Agency's online procurement system, indicating a formal and structured acquisition process for the required culture medium product.

Defense Logistics Agency

POSTED

DEADLINE

TEST KIT, SALMONELLAThe contract pertains to the procurement of a Salmonella test kit identified by NSN/Part Number 6550-01-360-5759, with a single unit requested under purchase request number 7017103971. The solicitation, numbered SPE2DS-26-T-143V, was issued by the Defense Logistics Agency under the Department of Defense and was posted on June 9, 2026. Interested parties were required to respond by June 15, 2026. The contract is a solicitation type with no specified set-aside type or NAICS code, indicating it is open to qualified suppliers without specific socioeconomic restrictions. The contract's place of performance and office address details are unspecified beyond being within the United States. This procurement is conducted under federal jurisdiction, specifically through the Defense Logistics Agency, which manages logistics and supply chain solutions for the Department of Defense. There is no contact information included for direct correspondence, but an online link to the solicitation is provided, enabling interested suppliers to access further details and submit responses.

Defense Logistics Agency

POSTED

DEADLINE

REAGENT SET, ANTIBODThe contract pertains to the procurement of a reagent set for antibodies, identified by NSN/Part Number 6550-01-204-5368, with a quantity of one unit requested under purchase request number 7017121423. The solicitation, labeled SPE2DS-26-T-148Q, was posted by the Defense Logistics Agency of the Department of Defense on June 11, 2026, with responses due by June 17, 2026. This contract is a federal solicitation intended for suppliers to provide the specified reagent set, but does not indicate any set-aside type or specify the size or type of business preferred for submission. The contract details include limited information about the place of performance or specific office address, implying that these details may be provided upon award or through direct inquiry. The solicitation is managed by the Defense Logistics Agency, responsible for supplying materials across the Department of Defense. Interested parties can access the complete solicitation documents and respond via the provided DLA Bid System electronic portal, facilitating a competitive procurement process for this specialized reagent set.

Defense Logistics Agency

POSTED

DEADLINE

in about 21 hours

Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune DiseaseThis contract seeks the development of innovative, rapid diagnostic assays aimed at addressing the critical need for early and accurate detection of multi-system autoimmune diseases. The intended diagnostic tool would enable primary care physicians to identify and predict tissue-specific manifestations of autoimmune conditions, improving patient management by facilitating timely specialist referrals. This approach leverages recent advancements in technology that allow for the detection of immune-mediated tissue stress through analysis of circulating cells and tissue-specific molecular markers. The solicitation is a total small business set-aside under the Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) mandate, targeting companies with fewer than 500 employees. Issued by the Department of Health and Human Services through the ARPA-H agency, the contract emphasizes accelerating translational technologies that can be implemented in primary care settings. Responses to the solicitation are due by July 10, 2026, and interested parties are encouraged to explore the detailed requirements and submission guidelines on the official SBIR portal.

POSTED

DEADLINE

Development of an annual test to inform women about their future fertilityThis contract involves the development of an annual diagnostic test designed to inform women about their future fertility by identifying new biomarkers that provide actionable insights for fertility planning. The test aims to assess a woman’s fertility status and predict the likely timeline for the onset of infertility, helping to guide decisions related to childbearing. The work is intended to generate data that will assist program managers in evaluating the feasibility of future initiatives focused on enhancing natural fertility before resorting to IVF treatments. Additionally, the project supports the advancement of women’s health monitoring tools by creating a test that is affordable, suitable for at least yearly use, and delivers straightforward results easily interpreted by patients and healthcare providers. The solicitation is issued by the Department of Health and Human Services through the ARPA-H agency, with a total small business set-aside designation, targeting companies with fewer than 500 employees under the SBIR/STTR mandate. The posted deadline for submission is July 10, 2026. This effort underscores a federal commitment to innovative women’s health solutions that enable proactive fertility management and aligns with the broader goal of improving reproductive health outcomes through accessible, user-friendly diagnostic technology.

POSTED

DEADLINE